AKT1 and cholangiocarcinoma: These data indicate that dihydromyricetin exerting the anti-tumor effects in CCA cells is through regulating the miR-21/PTEN/Akt axis and the miR-21/PTEN/Akt axis may be an important target for CCA treatment.